Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, non-randomized pilot study to evaluate the efficacy and tolerability of
combination quad-shot palliative radiotherapy with immunotherapy for
advanced/recurrent/metastatic head and neck cancer.